APDN Stock Summary and Trading Ideas (Applied Dna Sciences | NASDAQ:APDN)

Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Applied Dna Sciences trades on the NASDAQ stock market under the symbol APDN.

As of June 18, 2025, APDN stock price was flat at $4.73 with 19,859 million shares trading.

APDN has a beta of 3.00, meaning it tends to be more sensitive to market movements. APDN has a correlation of 0.06 to the broad based SPY ETF.

APDN has a market cap of $2.45 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, APDN traded as high as $110,249.40 and as low as $4.36.

The top ETF exchange traded funds that APDN belongs to (by Net Assets): VXF.

APDN has underperformed the market in the last year with a price return of -98.6% while the SPY ETF gained +10.5%. APDN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -82.8% and -7.3%, respectively, while the SPY returned +5.6% and +0.2%, respectively.

APDN support price is $4.09 and resistance is $5.37 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that APDN shares will trade within this expected range on the day.